LJI Instructor Haoyang Li receives $4.5M to pursue innovative therapeutics for cancers, infectious diseases, and chronic inflammation Li will capture key immune system molecules in action, with a new R01 grant from the National Institute of Allergy and Infectious Diseases

News: LJI Instructor Haoyang Li receives $4.5M to pursue innovative therapeutics for cancers, infectious diseases, and chronic inflammation

bit.ly/4rTU50k

@niaidnews.bsky.social #immunology #ChronicDisease #CancerImmunotherapies #InfectiousDisease #CryoEM

Researchers highlight #oncolytic #HerpesSimplexVirus (HSV-1) viruses as promising #CancerImmunotherapies, detailing advances in #glycoprotein retargeting, discussing molecular entry mechanisms, clinical successes, and future challenges.

#OpenAccess: doi.org/10.1016/j.ge...

Submit your poster abstracts for our Cancer Immunotherapy meeting by Feb. 20, 11:59pm MST. Connect with oncology experts & explore advancements in cancer immunotherapy and combination therapies! youtu.be/F8wZWueo_z4

#KSCancerImmune25 #cancerimmunotherapy #immunotherapy #cancerimmunotherapies

Ugur Sahin receives German #CancerAward 2019 for his seminal work on individualized #CancerImmunotherapies...